Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
MISSISSAUGA, ON, March 8, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and full year of 2023 after the market close on Thursday, March 14, 2024. The Company will also hold a conference call on Friday, March 15 at 8:30 ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: |
March 15, 2024 |
TIME: |
8:30AM |
DIAL-IN NUMBER: |
416-764-8650 or 888-664-6383 |
REPLAY: |
416-764-8677 or 888-390-0541 Code: 128854# |
Expires: March 22, 2024 |
|
WEBCAST: |
https://app.webinar.net/YqROVOGVJeP |
Cipher Pharmaceuticals (TSX: CPH, OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Graham Farrell, Investor Relations - Cipher Pharmaceuticals, [email protected], 416-842-9003
Share this article